Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin J Boeree

Showing results (1-10 of 123) with videos related to

Pageof 13
Sort By:
Recent Patents on Anti-Infective Drug Discovery|May 10, 2011
Global clinical trials for the treatment of TB with thioridazineMartin J Boeree
The New England Journal of Medicine|June 2, 2016
Therapy for Tuberculous MeningitisMartin J Boeree, Stephen H Gillespie, Michael Hoelscher, et al.
The New England Journal of Medicine|June 14, 2023
Treatment Strategy for Rifampin-Susceptible TuberculosisMartin J Boeree, Norbert Heinrich, Rob E Aarnoutse
American Journal of Respiratory and Critical Care Medicine|January 16, 2019
Conflicting Findings on an Intermediate Dose of Rifampicin for Pulmonary TuberculosisLindsey H M Te Brake, Martin J Boeree, Robert E Aarnoutse
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|April 25, 2012
Resistance mechanisms and drug susceptibility testing of nontuberculous mycobacteriaJakko van Ingen, Martin J Boeree, Dick van Soolingen, et al.
Tropical Medicine & International Health : TM & IH|March 8, 2011
The complexity of the adherence-response relationship in tuberculosis treatment: why are we still in the dark and how can we get out?Jossy van den Boogaard, Martin J Boeree, Gibson S Kibiki, et al.
Nature Clinical Practice. Rheumatology|November 28, 2008
Mycobacterial disease in patients with rheumatic diseaseJakko van Ingen, Martin J Boeree, P N Richard Dekhuijzen, et al.
Journal of Clinical Microbiology|December 28, 2012
Role of rpsA gene sequencing in diagnosis of pyrazinamide resistanceSami O Simons, Arnout Mulder, Jakko van Ingen, et al.
Expert Review of Anti-Infective Therapy|October 16, 2013
Drug treatment of pulmonary nontuberculous mycobacterial disease in HIV-negative patients: the evidenceJakko van Ingen, Beatriz E Ferro, Wouter Hoefsloot, et al.
International Journal of Antimicrobial Agents|May 14, 2013
Synergistic activity of rifampicin and ethambutol against slow-growing nontuberculous mycobacteria is currently of questionable clinical significanceJakko van Ingen, Wouter Hoefsloot, Johan W Mouton, et al.
Pageof 13

Showing results (1-10 of 123) with videos related to

Sort By:
Pageof 13
Recent Patents on Anti-Infective Drug Discovery|May 10, 2011
Global clinical trials for the treatment of TB with thioridazineMartin J Boeree
The New England Journal of Medicine|June 2, 2016
Therapy for Tuberculous MeningitisMartin J Boeree, Stephen H Gillespie, Michael Hoelscher, et al.
The New England Journal of Medicine|June 14, 2023
Treatment Strategy for Rifampin-Susceptible TuberculosisMartin J Boeree, Norbert Heinrich, Rob E Aarnoutse
American Journal of Respiratory and Critical Care Medicine|January 16, 2019
Conflicting Findings on an Intermediate Dose of Rifampicin for Pulmonary TuberculosisLindsey H M Te Brake, Martin J Boeree, Robert E Aarnoutse
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|April 25, 2012
Resistance mechanisms and drug susceptibility testing of nontuberculous mycobacteriaJakko van Ingen, Martin J Boeree, Dick van Soolingen, et al.
Tropical Medicine & International Health : TM & IH|March 8, 2011
The complexity of the adherence-response relationship in tuberculosis treatment: why are we still in the dark and how can we get out?Jossy van den Boogaard, Martin J Boeree, Gibson S Kibiki, et al.
Nature Clinical Practice. Rheumatology|November 28, 2008
Mycobacterial disease in patients with rheumatic diseaseJakko van Ingen, Martin J Boeree, P N Richard Dekhuijzen, et al.
Journal of Clinical Microbiology|December 28, 2012
Role of rpsA gene sequencing in diagnosis of pyrazinamide resistanceSami O Simons, Arnout Mulder, Jakko van Ingen, et al.
Expert Review of Anti-Infective Therapy|October 16, 2013
Drug treatment of pulmonary nontuberculous mycobacterial disease in HIV-negative patients: the evidenceJakko van Ingen, Beatriz E Ferro, Wouter Hoefsloot, et al.
International Journal of Antimicrobial Agents|May 14, 2013
Synergistic activity of rifampicin and ethambutol against slow-growing nontuberculous mycobacteria is currently of questionable clinical significanceJakko van Ingen, Wouter Hoefsloot, Johan W Mouton, et al.
Pageof 13